EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische Studie

Addition of trastuzumab to perioperative chemotherapy in HER2-positive gastroesophageal adenocarcinoma patients: A multicenter retrospective observational AGEO study

Anne-Esther Frydman, Antoine Drouillard, Emilie Soularue, Olivier Dubreuil, Aziz Zaanan, Anthony Turpin, David Tougeron, Solène Doat, Jean-Baptiste Bachet

Digestive and Liver Disease · 2024

DOI: 10.1016/j.dld.2023.06.007 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Digestive and Liver Disease, 2024. Verfasst von Anne-Esther Frydman und 8 weiteren Autor:innen. Beteiligte Einrichtung: Gastrointestinal Oncology Department Pitié-Salpétrière Hospital, Paris, France. Electronic address: anne-esther.frydman@aphp.fr. Hauptthemen laut MEDLINE: Stomach Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsAdenocarcinomaHumansTrastuzumabErb-b2 Receptor Tyrosine KinasesRetrospective Studies

Stichwörter der Autor:innen

Gastro-esophageal adenocarcinomaHER2-positivePerioperative chemotherapyTrastuzumab

Substanzen

TrastuzumabErb-b2 Receptor Tyrosine Kinases

Autor:innen und Institutionen

  • Gastrointestinal Oncology Department Pitié-Salpétrière Hospital, Paris, France. Electronic address: anne-esther.frydman@aphp.fr.
  • Gastrointestinal Oncology Department Dijon University Hospital, Dijon, France.
  • Gastrointestinal Oncology Department Montsouris Institute Hospital, Paris, France.
  • Oncology Department Croix-Saint-Simon Hospital, Paris, France.
  • Gastrointestinal Oncology Department European Georges Pompidou Hospital, Paris, France.
  • Oncology Department Lille University Hospital, Lille, France.

Zitieren

APA

Frydman, A. E., Drouillard, A., Soularue, E., Dubreuil, O., Zaanan, A., Turpin, A., Tougeron, D., Doat, S., & Bachet, J. B. (2024). Addition of trastuzumab to perioperative chemotherapy in HER2-positive gastroesophageal adenocarcinoma patients: A multicenter retrospective observational AGEO study. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2023.06.007

Vancouver

Frydman AE, Drouillard A, Soularue E, Dubreuil O, Zaanan A, Turpin A, et al. Addition of trastuzumab to perioperative chemotherapy in HER2-positive gastroesophageal adenocarcinoma patients: A multicenter retrospective observational AGEO study. Digestive and Liver Disease. 2024. doi:10.1016/j.dld.2023.06.007

BibTeX
@article{Frydman2024,
  author = {Frydman, Anne-Esther and Drouillard, Antoine and Soularue, Emilie and Dubreuil, Olivier and Zaanan, Aziz and Turpin, Anthony and Tougeron, David and Doat, Solène and Bachet, Jean-Baptiste},
  title = {Addition of trastuzumab to perioperative chemotherapy in HER2-positive gastroesophageal adenocarcinoma patients: A multicenter retrospective observational AGEO study},
  journal = {Digestive and Liver Disease},
  year = {2024},
  doi = {10.1016/j.dld.2023.06.007}
}
Kostenlos starten →